Comparing the Cost Effectiveness of Non-vitamin K Antagonist Oral Anticoagulants with Well-Managed Warfarin for Stroke Prevention in Atrial Fibrillation Patients at High Risk of Bleeding
about
Comparing the Cost Effectiveness of Non-vitamin K Antagonist Oral Anticoagulants with Well-Managed Warfarin for Stroke Prevention in Atrial Fibrillation Patients at High Risk of Bleeding
description
scientific article published on 01 August 2018
@en
name
Comparing the Cost Effectivene ...... ients at High Risk of Bleeding
@en
type
label
Comparing the Cost Effectivene ...... ients at High Risk of Bleeding
@en
prefLabel
Comparing the Cost Effectivene ...... ients at High Risk of Bleeding
@en
P1476
Comparing the Cost Effectivene ...... ients at High Risk of Bleeding
@en
P2093
Alexa R Hospodar
Kenneth J Smith
P304
P356
10.1007/S40256-018-0279-Y
P577
2018-08-01T00:00:00Z